Observational studyThe pharmacogenomics journal2020

Effect of genetic polymorphisms in CYP3A4, CYP3A5, and m-TOR on everolimus blood exposure and clinical outcomes in cancer patients.

Stéphanie Bonnet et al.PubMed ↗Publisher ↗

No numbers read from the abstract.